Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Applying a specific inhibitor lightens skin and hair color.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

ROXY proteins help plants respond to nitrate shortage by affecting nutrient sensing and growth.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

EGFR inhibitors can cause yellowish skin eruptions.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Finasteride reduces movement issues in Parkinson's disease rats.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Finasteride affects young male rats' brain function and behavior negatively.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Dutasteride and finasteride affect different cell types differently.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.